Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial
Ramzi A Tabbalat, Imad Alhaddad, Ayman Hammoudeh, Yousef S Khader, Hassan Abu Khalaf, Mohammad Obaidat, Jude Barakat, Ramzi A Tabbalat, Imad Alhaddad, Ayman Hammoudeh, Yousef S Khader, Hassan Abu Khalaf, Mohammad Obaidat, Jude Barakat
Abstract
Background: Studies using 1 mg of colchicine to prevent postoperative atrial fibrillation (POAF) reported conflicting results. Moreover, colchicine was associated with significant gastrointestinal (GI) side effects. This study examined whether low-dose colchicine effectively prevents POAF and whether low-dose therapy is associated with lower rates of colchicine-induced GI side effects.
Methods: In this prospective, randomized, double-blind, placebo-controlled study, consecutive adult patients admitted for elective cardiac surgeries randomly received a 1-mg dose of colchicine (n = 81) or placebo (n = 71) orally 12 to 24 hours before surgery followed by a daily dose of 0.5 mg until hospital discharge. The primary efficacy endpoint was the development of at least one episode of POAF of ≥5 minutes. The primary safety endpoint was the development of adverse events, especially diarrhea.
Results: The in-hospital mortality rate was 3.9%. POAF occurred in 13 patients (16.1%) in the colchicine group and 13 patients (18.3%) in the placebo group (odds ratio 0.85 [95% Confidence Interval = 0.37-1.99]). Diarrhea occurred in two patients in each group and necessitated treatment discontinuation in one patient in each group.
Conclusion: Low-dose colchicine did not prevent POAF in patients undergoing cardiac surgery. These results should be interpreted cautiously because of the small sample size and early study termination.ClinicalTrials.gov Unique Identifier number: NCT03015831.
Keywords: Atrial fibrillation; arrhythmia; cardiac surgery; colchicine; gastrointestinal toxicity; randomized controlled trial.
Figures
References
- Lauer M, Eagle K, Buckley M, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–378.
- Filardo G, Damiano RJ, Jr, Ailawadi G, et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart 2018; 104: 985–992.
- Polat A, Şahin İ, Yücel C, et al. Coronary vasculature and postoperative atrial fibrillation: a risk factor analysis. Turk Gogus Kalp Dama 2013; 21: 567–573.
- Zaman A, Archbold R, Helft G, et al. Atrial Fibrillation After Coronary Artery Bypass Surgery. Circulation 2000; 101: 1403–1408.
- Nair S. Atrial fibrillation after cardiac surgery. Ann Card Anaesth 2010; 13: 196–205.
- Tamis J, Steinberg J. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol 2000; 23: 155–159.
- Lazar H, Fitzgerald C, Gross S, et al. Determinants of Length of Stay After Coronary Artery Bypass Graft Surgery. Circulation 1995; 92: 20–24.
- Alqahtani A. Atrial fibrillation post cardiac surgery trends toward management. Heart Views 2010; 11: 57–63.
- Chung M, Martin D, Sprecher D, et al. C-Reactive Protein Elevation in Patients with Atrial Arrhythmias. Circulation 2001; 104: 2886–2891.
- Ishii Y, Schuessler R, Gaynor S, et al. Inflammation of Atrium After Cardiac Surgery Is Associated with Inhomogeneity of Atrial Conduction and Atrial Fibrillation. Circulation 2005; 111: 2881–2888.
- Ishii Y, Schuessler R, Gaynor S, et al. Postoperative atrial fibrillation: the role of the inflammatory response. J Thorac Cardiovasc Surg 2017; 153: 1357–1365.
- Ho K, Tan J. Benefits and Risks of Corticosteroid Prophylaxis in Adult Cardiac Surgery. Circulation 2009; 119: 1853–1866.
- Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Post pericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011; 124: 2290–2295.
- Imazio M, Brucato A, Ferrazzi P, et al. . Colchicine for Prevention of Post pericardiotomy Syndrome and Postoperative Atrial Fibrillation. The COPPS-2 randomized clinical trial. JAMA 2014; 312: 1016–1023.
- Vrachatis D, Kossyvakis C, Angelidis C, et al. Colchicine in Post-operative Atrial Fibrillation: a Review. Curr Pharm Des 2018; 24: 695–701.
- Tabbalat R, Hamad N, Alhaddad I, et al. Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial. Am Heart J 2016; 178: 102–107.
- Lee J, Singh N, Howe C, et al. Colchicine for Prevention of Post-Operative Atrial Fibrillation. JACC Clin Electrophysiol 2016; 2: 78–85.
- Lennerz C, Barman M, Tantawy M, et al. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis. Int J Cardiol 2017; 249: 127–137.
- Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment with Colchicine in Acute Myocardial Infarction. Circulation 2015; 132: 1395–1403.
- Nidorf S, Eikelboom J, Budgeon C, et al. Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease. J Am Coll Cardiol 2013; 61: 404–410.
- Tardif JC, Kouz S, Waters D, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019; 381: 2497–2505.
Source: PubMed